Rip 200 by Onyx-Pharma is a multi-compound injectable anabolic blend containing Testosterone Propionate 100mg/ml, Trenbolone Acetate 50mg/ml and Drostanolone Propionate 50mg/ml. The formula combines three short-acting anabolic-androgenic compounds in one presentation and is commonly researched alongside lean mass, muscle definition, strength, body composition and physique conditioning goals withi...
Rip 200 by Onyx-Pharma is an injectable anabolic blend containing three distinct active compounds:
Together, these provide a total labelled concentration of 200mg/ml, which explains the Rip 200 product name.
The formulation combines Testosterone, Trenbolone and Drostanolone, three anabolic-androgenic compounds with different pharmacological characteristics but overlapping activity through androgen-receptor signalling.
Because all three components use relatively short esters, Rip 200 differs from long-acting products based on esters such as Enanthate, Cypionate, Decanoate or Undecylenate.
Within Eroid's Mass Gainers range, customers can compare Rip 200 with single-compound and blended products according to formulation, ester profile, concentration and brand.
The three active compounds in Rip 200 primarily exert their anabolic-androgenic effects through interaction with androgen receptors.
After the esterified compounds are released and converted into their active hormonal forms, androgen-receptor signalling influences gene transcription and biological pathways associated with protein metabolism, skeletal muscle and androgen-responsive tissues.
Testosterone Propionate provides the testosterone component of the blend.
Testosterone has both anabolic and androgenic activity and plays an important physiological role in protein metabolism, muscle tissue, bone physiology and androgen-dependent functions.
The propionate ester gives it a relatively short release profile compared with longer Testosterone esters.
Trenbolone Acetate contributes potent anabolic-androgenic activity through strong androgen-receptor interaction.
Its pharmacology is frequently associated with discussions involving protein metabolism, nitrogen balance and body composition.
The acetate ester is comparatively short acting.
Drostanolone Propionate, commonly associated with the Masteron name, is a DHT-derived anabolic-androgenic compound.
It does not aromatise into estrogen and is therefore commonly associated with searches involving muscle definition, conditioning and reduced estrogen-mediated water retention.
The defining characteristic of Rip 200 is that all three compounds are combined within one injectable formulation.
Although their individual pharmacological profiles differ, each interacts with androgen-responsive pathways. This makes androgen-receptor signalling, protein metabolism and muscle tissue central concepts when understanding the blend.
The Eroid Mass Gainers category includes products researched for several different physique goals, from overall body-mass increases to lean-mass development and conditioning.
Rip 200 fits more naturally into the latter type of product research because its formula combines Testosterone, Trenbolone and Drostanolone rather than relying on a single compound associated primarily with scale-weight increases.
Relevant bodybuilding and mass-gain concepts include:
Muscle development itself depends on factors including progressive training, sufficient dietary protein, appropriate energy intake and adequate recovery.
For customers browsing Eroid, Rip 200 can therefore be compared against other Mass Gainers and injectable products by looking at its three-component formula rather than treating all products in the category as interchangeable.
The name reflects the combined labelled concentration of the three active ingredients: 100mg/ml Testosterone Propionate + 50mg/ml Trenbolone Acetate + 50mg/ml Drostanolone Propionate = 200mg/ml.
Rip 200 is a three-compound injectable blend. It combines Testosterone Propionate, Trenbolone Acetate and Drostanolone Propionate in one formulation. This distinguishes it from single-active-ingredient products elsewhere in Eroid's injectable range.
An ester modifies how quickly an injectable hormone is released from its depot. Propionate and Acetate are relatively short esters, so products using them generally have shorter release profiles than Enanthate, Cypionate, Decanoate or Undecylenate formulations.
Compare the active ingredients, concentration, ester profile, formulation and brand. Rip 200 is particularly distinctive because it combines three short-ester compounds rather than relying on one anabolic hormone.
Eroid categories reflect how customers commonly research products. Rip 200 combines anabolic compounds associated with muscle tissue, protein metabolism and physique development, so it can appear within Mass Gainers even though some of its individual ingredients are frequently discussed in lean-mass or conditioning contexts.
At Eroid, product identity, packaging details and relevant product information are checked as part of our product-handling process before products are offered for sale. We focus on providing customers with clearly identified products and transparent specifications across different brands and categories.
For Rip 200 โ Onyx-Pharma, important verification characteristics include:
Brand: Onyx-Pharma
Product: Rip 200
Active substance 1: Testosterone Propionate โ 100mg/ml
Active substance 2: Trenbolone Acetate โ 50mg/ml
Active substance 3: Drostanolone Propionate โ 50mg/ml
Total labelled concentration: 200mg/ml
Presentation: Injectable anabolic blend
Ester profile: Short-ester formulation
Category: Mass Gainers / Injectable Products
SKU: S1016
For multi-compound injectable products, quality assessment can include characteristics such as active-substance identity, concentration, purity, formulation consistency and packaging integrity.
Where batch-specific analytical documentation is displayed, reported analytical values should correspond to the particular tested batch rather than being presented as generic laboratory results for every batch.
No reviews yet for this product.
Eroid offers UK shipping and international delivery to eligible destinations worldwide, giving customers access to products across multiple brands and categories where destination requirements permit.
Orders are handled with attention to:
Because Rip 200 โ Onyx-Pharma is an injectable multi-compound formulation, customers should follow the storage and handling information stated on the original product packaging once received.
International availability and shipping eligibility can vary according to destination and applicable requirements.